论文信息 - An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer - 字舞流文

An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer

G. Lou | Qi Zhou | H. Pan | Y. Meng | Hui Zhang | Yaping Zhu | S. Yao | Quanren Wang | K. Gu | R. An | J. Xiong | Ning Li | Lingying Wu | Jing Wang | W. Duan | Hongyan Guo | R. Yin | Xiaohua Wu | Wen-jing Hu | Jihong Liu | Xin-Min Yang | Gui-Chen Li | Li Wang | Jianqing Zhu | Xin Zhang | Ben Zhang | Yuting Wang | Qiang Wu | H. Bu | X. Wan | Qiang Wu